These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36685833)

  • 41. Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma.
    Chen B; Deng T; Deng L; Yu H; He B; Chen K; Zheng C; Wang D; Wang Y; Chen G
    BMC Cancer; 2021 Nov; 21(1):1211. PubMed ID: 34772375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer.
    Zou X; Guo Y; Mo Z
    Front Genet; 2022; 13():905988. PubMed ID: 36419829
    [No Abstract]   [Full Text] [Related]  

  • 43. Identification of an autophagy-related gene signature for predicting prognosis and immune activity in pancreatic adenocarcinoma.
    Deng J; Zhang Q; Lv L; Ma P; Zhang Y; Zhao N; Zhang Y
    Sci Rep; 2022 Apr; 12(1):7006. PubMed ID: 35488119
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma.
    Liu XS; Gao Y; Liu C; Chen XQ; Zhou LM; Yang JW; Kui XY; Pei ZJ
    Front Oncol; 2020; 10():606735. PubMed ID: 33604289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. lncRNAs Functioned as ceRNA to Sponge miR-15a-5p Affects the Prognosis of Pancreatic Adenocarcinoma and Correlates With Tumor Immune Infiltration.
    Wang Y; Wang Z; Li K; Xiang W; Chen B; Jin L; Hao K
    Front Genet; 2022; 13():874667. PubMed ID: 35899199
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Zheng Q; Xie Y; Xu L; Chen D; Wu J; Liu S; Wu L; Fang P; Xie F
    J Gastrointest Oncol; 2024 Aug; 15(4):1746-1759. PubMed ID: 39279982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GLUT1 Regulates the Tumor Immune Microenvironment and Promotes Tumor Metastasis in Pancreatic Adenocarcinoma via ncRNA-mediated Network.
    Li F; He C; Yao H; Liang W; Ye X; Ruan J; Lin L; Zou J; Zhou S; Huang Y; Li Y; Chen S; Huang K; Lian G; Chen S
    J Cancer; 2022; 13(8):2540-2558. PubMed ID: 35711842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PANX1 is a potential prognostic biomarker associated with immune infiltration in pancreatic adenocarcinoma: A pan-cancer analysis.
    Bao L; Sun K; Zhang X
    Channels (Austin); 2021 Dec; 15(1):680-696. PubMed ID: 34796785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analyzing the role of
    Xu D; Jia M; Yang F; Zhang X; Jiang K
    J Gastrointest Oncol; 2024 Aug; 15(4):1760-1776. PubMed ID: 39279979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Developing and validating a survival prediction model based on blood exosomal ceRNA network in patients with PAAD.
    Wang S; Xu L; Zhu K; Zhu H; Zhang D; Wang C; Wang Q
    BMC Med Genomics; 2022 Dec; 15(1):260. PubMed ID: 36522691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression and prognostic impact of FZDs in pancreatic adenocarcinoma.
    Li Y; Liu Z; Zhang Y
    BMC Gastroenterol; 2021 Feb; 21(1):79. PubMed ID: 33618667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The potential use and experimental validation of genomic instability-related lncRNA in pancreatic carcinoma.
    Xia X; Zhao S; Song X; Zhang M; Zhu X; Li C; Chen W; Zhao D
    Medicine (Baltimore); 2023 Sep; 102(37):e35300. PubMed ID: 37713870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cuproptosis-Related Gene
    Fang Z; Wang W; Liu Y; Hua J; Liang C; Liu J; Zhang B; Shi S; Yu X; Meng Q; Xu J
    Curr Oncol; 2023 Mar; 30(3):2997-3019. PubMed ID: 36975441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LINC01232 Sponges Multiple miRNAs and Its Clinical Significance in Pancreatic Adenocarcinoma Diagnosis and Prognosis.
    Du W; Lei C; Wang Y; Ding Y; Tian P
    Technol Cancer Res Treat; 2021; 20():1533033820988525. PubMed ID: 33506742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma.
    Ye Y; Zhao Q; Wu Y; Wang G; Huang Y; Sun W; Zhang M
    Front Genet; 2022; 13():989719. PubMed ID: 36212154
    [No Abstract]   [Full Text] [Related]  

  • 56. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
    Yan C; Niu Y; Li F; Zhao W; Ma L
    J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer.
    Zhang J; Tian Y; Mo S; Fu X
    Int J Gen Med; 2022; 15():3077-3096. PubMed ID: 35330878
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Wu Q; Li J; Wang P; Peng Q; Kang Z; Deng Y; Li J; Yan D; Ge F; Chen Y
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36981005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma.
    Huang H; Zhou W; Chen R; Xiang B; Zhou S; Lan L
    Front Mol Biosci; 2021; 8():611508. PubMed ID: 33681290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined Evaluation of mRNA and Protein Expression, Promoter Methylation, and Immune Infiltration of UBE2I in Pan-Digestive System Tumors.
    Huang S; Wang X; Luo K; Zhang X; Liu Z; Li R
    Oxid Med Cell Longev; 2022; 2022():1129062. PubMed ID: 36193060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.